安锐生物
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing 2023-03-10 09:00
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round 2021-11-24 16:11
1